Can butylphthalide, derived from celery seed, improve recovery outcomes after a stroke caused by a clot?

### Can Butylphthalide Improve Stroke Recovery? Butylphthalide, a new medication derived from celery seed, has shown promise in improving outcomes for patients who have suffered a stroke caused by a blood clot. According to a recent study, patients who received butylphthalide in addition to standard clot treatment had better recovery outcomes 90 days after the stroke compared to those who received a placebo. The study was conducted in China and involved 1,216 patients across 59 medical centers. Patients were randomly assigned to receive either butylphthalide or a placebo, along with their initial clot treatment. The results showed that those who took butylphthalide were 70% more likely to have favorable outcomes, including reduced neurological symptoms and better daily functioning. However, more research is needed to fully understand how butylphthalide works and its potential benefits for stroke patients worldwide.###